+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019

  • ID: 4861084
  • Report
  • November 2019
  • Region: Global
  • 113 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Alere Inc
  • Bio Techne Corp
  • Cepheid
  • Enzo Biochem Inc
  • GRANT Life Sciences, Inc.
  • MDxHealth SA
  • MORE
Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019

Summary

The Publisher's Medical Devices sector report, “Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019" provides an overview of Cervical Cancer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cervical Cancer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by the Publisher's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Cervical Cancer Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cervical Cancer Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cervical Cancer Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Alere Inc
  • Bio Techne Corp
  • Cepheid
  • Enzo Biochem Inc
  • GRANT Life Sciences, Inc.
  • MDxHealth SA
  • MORE
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Cervical Cancer Diagnostic Tests Overview

3 Products under Development
3.1 Cervical Cancer Diagnostic Tests - Pipeline Products by Stage of Development
3.2 Cervical Cancer Diagnostic Tests - Pipeline Products by Territory
3.3 Cervical Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
3.4 Cervical Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
3.5 Cervical Cancer Diagnostic Tests - Ongoing Clinical Trials

4 Cervical Cancer Diagnostic Tests - Pipeline Products under Development by Companies
4.1 Cervical Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development
4.2 Cervical Cancer Diagnostic Tests - Pipeline Products by Stage of Development

5 Cervical Cancer Diagnostic Tests Companies and Product Overview
5.1 Alere Inc Company Overview
5.1.1 Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Augusta University Company Overview
5.2.1 Augusta University Pipeline Products & Ongoing Clinical Trials Overview
5.3 Becton Dickinson and Co Company Overview
5.3.1 Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview
5.4 Bio Techne Corp Company Overview
5.4.1 Bio Techne Corp Pipeline Products & Ongoing Clinical Trials Overview
5.5 BioAffinity Technologies, Inc. Company Overview
5.5.1 BioAffinity Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.6 BioMark Diagnostics Inc Company Overview
5.6.1 BioMark Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 BioMark Technologies Inc Company Overview
5.7.1 BioMark Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.8 Cepheid Company Overview
5.8.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview
5.9 China Sky One Medical Inc Company Overview
5.9.1 China Sky One Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.10 Cytosystems Ltd Company Overview
5.10.1 Cytosystems Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.11 Enzo Biochem Inc Company Overview
5.11.1 Enzo Biochem Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Exact Sciences Corp Company Overview
5.12.1 Exact Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview
5.13 GenomicTree Inc Company Overview
5.13.1 GenomicTree Inc Pipeline Products & Ongoing Clinical Trials Overview
5.14 GRANT Life Sciences, Inc. Company Overview
5.14.1 GRANT Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.15 HLL Lifecare Ltd Company Overview
5.15.1 HLL Lifecare Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.16 Louisville Bioscience, Inc. Company Overview
5.16.1 Louisville Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.17 MDNA Life Sciences Inc Company Overview
5.17.1 MDNA Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.18 MDxHealth SA Company Overview
5.18.1 MDxHealth SA Pipeline Products & Ongoing Clinical Trials Overview
5.19 Milagen Inc Company Overview
5.19.1 Milagen Inc Pipeline Products & Ongoing Clinical Trials Overview
5.20 Olympia Diagnostics Inc Company Overview
5.20.1 Olympia Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.21 Oncgnostics GmbH Company Overview
5.21.1 Oncgnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.22 ONCOVEDA Cancer Research Center Company Overview
5.22.1 ONCOVEDA Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview
5.23 Precision Biologics Inc Company Overview
5.23.1 Precision Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.24 US Biomarkers Inc Company Overview
5.24.1 US Biomarkers Inc Pipeline Products & Ongoing Clinical Trials Overview
5.25 XEPTAGEN SpA Company Overview
5.25.1 XEPTAGEN SpA Pipeline Products & Ongoing Clinical Trials Overview

6 Cervical Cancer Diagnostic Tests - Recent Developments
6.1 Nov 05, 2019: BD announces results for 2019 fourth fiscal quarter and full year; provides fiscal 2020 guidance
6.2 Oct 30, 2019: Genomic Vision: Financial information for the third quarter of 2019
6.3 Oct 23, 2019: AdvaMed Statement on BD Sterilization Plant in Georgia
6.4 Oct 22, 2019: Quest Diagnostics reports third quarter 2019 financial results
6.5 Oct 03, 2019: Genomic Vision and PolyAn sign an agreement for the production and supply of Coverslips
6.6 Sep 26, 2019: BD announces leadership succession plan
6.7 Sep 24, 2019: Genomic Vision: First-half 2019 results
6.8 Sep 10, 2019: Quest Diagnostics names Manuel O. Méndez as new commercial leader
6.9 Aug 29, 2019: MDxHealth reports half year 2019 financial results and strategic update
6.10 Aug 26, 2019: New technique isolates placental cells for non-invasive genetic testing
6.11 Aug 20, 2019: Cancer Genetics reports second quarter 2019 financial results and provides strategic business update
6.12 Aug 06, 2019: BD announces results for 2019 third fiscal quarter; reaffirms fiscal 2019 guidance

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact Us
7.4 Disclaimer

List of Tables
Table 1: Cervical Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Table 2: Cervical Cancer Diagnostic Tests - Pipeline Products by Territory
Table 3: Cervical Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
Table 4: Cervical Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
Table 5: Cervical Cancer Diagnostic Tests - Ongoing Clinical Trials
Table 6: Cervical Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development
Table 7: Cervical Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Table 8: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: NMP179 Test - Product Status
Table 10: NMP179 Test - Product Description
Table 11: Augusta University Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Folate Receptor Biomarker Test - Cervical Cancer Diagnostic Tests - Product Status
Table 13: Folate Receptor Biomarker Test - Cervical Cancer Diagnostic Tests - Product Description
Table 14: Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview
Table 15: BD SurePath Plus Molecular Pap Test System - Product Status
Table 16: BD SurePath Plus Molecular Pap Test System - Product Description
Table 17: Biomarker Test - Cervical Cancer Diagnostic Tests - Product Status
Table 18: Biomarker Test - Cervical Cancer Diagnostic Tests - Product Description
Table 19: Becton Dickinson and Co - Ongoing Clinical Trials Overview
Table 20: BD SurePath Plus Molecular Pap Test System - Validation of High Resolution Microendoscope in the Screening of Cervical Cancer Precursor Lesions in Brazil: UH3 - Brazil
Table 21: Bio Techne Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 22: RNAscope HPV Assay - Cervical Cancer Diagnostic Tests - Product Status
Table 23: RNAscope HPV Assay - Cervical Cancer Diagnostic Tests - Product Description
Table 24: BioAffinity Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 25: CyPath Diagnostic Assay - Cervical Cancer Diagnostic Tests - Product Status
Table 26: CyPath Diagnostic Assay - Cervical Cancer Diagnostic Tests - Product Description
Table 27: BioMark Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Metabolomics-based Diagnostic Assay - Cervical Cancer Diagnostic Tests - Product Status
Table 29: Metabolomics-based Diagnostic Assay - Cervical Cancer Diagnostic Tests - Product Description
Table 30: BioMark Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Biomarker Assay - Cervical Cancer Diagnostic Tests - Product Status
Table 32: Biomarker Assay - Cervical Cancer Diagnostic Tests - Product Description
Table 33: Cepheid Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Xpert Molecular PAP Assay - Product Status
Table 35: Xpert Molecular PAP Assay - Product Description
Table 36: China Sky One Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Diagnostic Kit - Carcinoma Cervix - Product Status
Table 38: Diagnostic Kit - Carcinoma Cervix - Product Description
Table 39: Cytosystems Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Laboratory-Based Diagnostic Test - Cervical Cancer Diagnostic Tests - Product Status
Table 41: Laboratory-Based Diagnostic Test - Cervical Cancer Diagnostic Tests - Product Description
Table 42: Enzo Biochem Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 43: p16 Biomarker - Cervical Cancer Diagnostic Tests - Product Status
Table 44: p16 Biomarker - Cervical Cancer Diagnostic Tests - Product Description
Table 45: Exact Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 46: Liquid Biopsy Test - Cervical Cancer Diagnostic Tests - Product Status
Table 47: Liquid Biopsy Test - Cervical Cancer Diagnostic Tests - Product Description
Table 48: GenomicTree Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 49: EarlyTect Cervical Cancer Diagnostic Tests - Product Status
Table 50: EarlyTect Cervical Cancer Diagnostic Tests - Product Description
Table 51: Screening Test - Cervical Cancer Diagnostic Tests - Product Status
Table 52: Screening Test - Cervical Cancer Diagnostic Tests - Product Description
Table 53: GRANT Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 54: Serum-Based Test - Cervical Cancer Diagnostic Tests - Product Status
Table 55: Serum-Based Test - Cervical Cancer Diagnostic Tests - Product Description
Table 56: HLL Lifecare Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 57: Diagnostic ELISA - Cervical Cancer Diagnostic Tests - Product Status
Table 58: Diagnostic ELISA - Cervical Cancer Diagnostic Tests - Product Description
Table 59: Louisville Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 60: Cervical Cancer Remission pT Test - Product Status

List of Figures
Figure 1: Cervical Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Figure 2: Cervical Cancer Diagnostic Tests - Pipeline Products by Territory
Figure 3: Cervical Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
Figure 4: Cervical Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
Figure 5: Cervical Cancer Diagnostic Tests - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 3
  • Alere Inc
  • Augusta University
  • Becton Dickinson and Co
  • Bio Techne Corp
  • BioAffinity Technologies, Inc.
  • BioMark Diagnostics Inc
  • BioMark Technologies Inc
  • Cepheid
  • China Sky One Medical Inc
  • Cytosystems Ltd
  • Enzo Biochem Inc
  • Exact Sciences Corp
  • GenomicTree Inc
  • GRANT Life Sciences, Inc.
  • HLL Lifecare Ltd
  • Louisville Bioscience, Inc.
  • MDNA Life Sciences Inc
  • MDxHealth SA
  • Milagen Inc
  • Olympia Diagnostics Inc
  • Oncgnostics GmbH
  • ONCOVEDA Cancer Research Center
  • Precision Biologics Inc
  • US Biomarkers Inc
  • XEPTAGEN SpA
Note: Product cover images may vary from those shown
Adroll
adroll